$AIM Folks taking "sell the news" to a whole new f'n level here in AIM...but we are stabilizing here in the 2.30 range. I don't care about the fluff news sell-offs, there are potentially millions of new Covid-19 related CFS patients worldwide. AIM has the only drug approved anywhere in the world to treat CFS. This is a wet dream set-up for this company. Must be patient.
  • 3
3 Likes